ICH
ICH Q7 19.21
19. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS
Section text
A quality unit(s) independent from production should be established for the approval or rejection of each batch of API for use in clinical trials.
Source: International Council for Harmonisation (ICH) · © ICH. Per the legal notice in each guideline, the document may be used, reproduced and distributed provided ICH's copyright is acknowledged; any adaptation or translation must be labelled as such and must not imply ICH endorsement. · retrieved 2026-11-15